View Article

  • Formulation and Evaluation of a Vitamin B12 Oral Dispersible Film Using Polymers for Enhanced Patient Compliance in Neuropathy– A Review

  • RJS College of Pharmacy Kokamthan, Koapargaon

Abstract

Peripheral neuropathy is a common neurological disorder often associated with vitamin B12 deficiency. Conventional oral dosage forms such as tablets and capsules present challenges including swallowing difficulty, poor compliance, and delayed onset of action, particularly in elderly and neuropathic patients. Oral dispersible films (ODFs) have emerged as a promising drug delivery system due to their rapid disintegration, ease of administration, and improved bioavailability. This review focuses on the formulation strategies, polymer selection, evaluation parameters, and therapeutic advantages of vitamin B12 oral dispersible films. Emphasis is placed on enhancing patient compliance and therapeutic efficacy in neuropathy management through innovative film-based drug delivery systems. Peripheral neuropathy is a prevalent neurological disorder often associated with vitamin B12 deficiency, leading to nerve damage and impaired neurological function. Conventional oral dosage forms of vitamin B12, such as tablets and capsules, are associated with limitations including swallowing difficulty, delayed onset of action, and poor patient compliance, particularly among geriatric and neuropathic patients. Oral dispersible films (ODFs) have emerged as a novel and patient-friendly drug delivery system that rapidly disintegrates in the oral cavity without the need for water, ensuring ease of administration and improved adherence. This review highlights the formulation strategies and evaluation parameters involved in the development of vitamin B12 oral dispersible films using various film-forming polymers. Key aspects discussed include polymer selection, plasticizers, manufacturing techniques, and physicochemical and performance evaluation of the films. The potential of oral dispersible films to enhance bioavailability, provide rapid therapeutic action, and improve patient compliance in the management of neuropathy is emphasized. The review concludes that vitamin B12 oral dispersible films represent a promising alternative to conventional dosage forms for effective neuropathy treatment.

Keywords

Vitamin B12, Oral Dispersible Film, Neuropathy, Polymers, Patient Compliance, Fast Dissolving Drug Delivery System

Introduction

Neuropathy is characterized by nerve damage resulting in symptoms such as numbness, tingling, pain, and muscle weakness. Vitamin B12 (cobalamin) plays a crucial role in nerve regeneration, myelin synthesis, and neurological function. Deficiency of vitamin B12 is a well-recognized cause of peripheral neuropathy. Traditional dosage forms of vitamin B12, including tablets and injections, have limitations such as poor patient adherence, swallowing difficulties, and invasiveness. Oral dispersible films offer a novel approach that overcomes these drawbacks, making them particularly beneficial for geriatric, paediatric, and neurologically impaired patients.

Role of Vitamin B12 in Neuropathy

Vitamin B12 is essential for: -

  • DNA synthesis and red blood cell formation
  • Maintenance of myelin sheath
  • Neuronal repair and regeneration

Deficiency leads to demyelination and axonal degeneration, contributing to neuropathic symptoms. Supplementation of vitamin B12 is a cornerstone in the management of neuropathy, especially in diabetic, alcoholic, and elderly patients.

Oral Dispersible Films: An Overview

Oral dispersible films are thin, flexible polymeric strips that rapidly disintegrate when placed on the tongue, releasing the drug without the need for water.

Advantages of ODFs

  • Rapid onset of action
  • Improved patient compliance
  • Ease of administration
  • Avoidance of first-pass metabolism (partial)
  • Accurate dosing
  • Enhanced bioavailability

Polymers Used in Vitamin B12 Oral Dispersible Films

Polymers play a vital role in film formation, drug release, and mechanical strength.

Commonly Used Polymers

  • Hydroxypropyl Methylcellulose (HPMC) – good film-forming ability
  • Polyvinyl Alcohol (PVA) – flexibility and strength
  • Pullulan – fast disintegration and transparency
  • Sodium Alginate – bioadhesive properties
  • Carboxymethyl Cellulose (CMC) – hydrophilic nature

Plasticizers

Plasticizers such as glycerin, polyethylene glycol (PEG), and propylene glycol are added to improve flexibility and prevent brittleness.

Formulation of Vitamin B12 Oral Dispersible Films

The most commonly used method is the solvent casting technique, which involves:

  1. Dissolving polymer in solvent
  2. Adding vitamin B12 and excipients
  3. Casting the solution onto a flat surface
  4. Drying and cutting into uniform films

Other excipients include sweeteners, flavoring agents, saliva-stimulating agents, and coloring agents to improve palatability and patient acceptance.

Evaluation Parameters of Oral Dispersible Films

ODFs are evaluated for both physical and functional properties:

Physicochemical Evaluation

  • Thickness
  • Weight variation
  • Surface pH
  • Folding endurance
  • Moisture content

Mechanical Properties

  • Tensile strength
  • Percent elongation

Performance Evaluation

  • Disintegration time
  • Drug content uniformity
  • In vitro dissolution studies

These parameters ensure consistency, stability, and efficacy of the formulation.

Stability Studies

Stability studies are conducted as per ICH guidelines to assess the effect of temperature and humidity on drug content, mechanical strength, and disintegration time over a specified period.

Patient Compliance and Therapeutic Benefits

Vitamin B12 oral dispersible films significantly enhance patient compliance by:

  • Eliminating swallowing difficulties
  • Reducing dosing frequency
  • Providing rapid relief
  • Improving adherence in long-term neuropathy treatment

This delivery system is especially advantageous for elderly patients and those with neurological impairments.

Common Types of Neuropathy

An estimated 20 million people in the United States have some form of neuropathy. As we mentioned, there are five main categories to consider. Common types of neuropathy are broken down for you below:

Peripheral Neuropathy

Peripheral Neuropathy is the most common form of neuropathy in patients.  This condition results from damage to the peripheral nervous system — the massive communications network that manages information between the central nervous system (the brain and spinal cord) to every other part of your body.  This particular nerve damage affects areas such as your toes, feet, legs, fingers, hands and arms. Many patients find that complementary and alternative therapies are effective in managing pain caused by peripheral neuropathy.

Proximal Neuropathy

Proximal Neuropathy is the second most common form of neuropathy. This form of neuropathy encompasses nerve damage in your thighs, hips or gluteal areas of your body. The condition usually affects one side of the body, but can spread to the other side as well.

Cranial Neuropathy

Cranial Neuropathy is a condition describing nerve damage to any of the 12 cranial nerves. The cranial nerves are those that travel from your brain or brainstem. These nerves affect areas like the face and eyes. Johns Hopkins’ medical library breaks down the the different types of cranial neuropathies as:

  • Bell’s palsy. This condition occurs when the facial nerve (seventh cranial nerve) is affected.
  • Microvascular cranial nerve palsy. This condition affects the nerves in the eye. It is most common in people who have diabetes and in those who have high blood pressure.
  • Third nerve palsy. This condition affects the third cranial nerve. This nerve helps manage a muscle that controls eye movement.
  • Fourth nerve palsy. This is also called superior oblique palsy. It affects the superior oblique muscle, which helps you converge your eyes (to look at the tip of your nose).
  • Sixth nerve palsy. This is also called cranial nerve VI or abducens palsy. It affects the sixth cranial nerve, which also helps control eye movement.
  • Multiple cranial neuropathies (MCN). If several different cranial nerves are affected, it is referred to as multiple cranial neuropathies.
  • Autonomic Neuropathy

Autonomic Neuropathy occurs when nerves of your involuntary nervous system (the heart, circulation, digestion, sweat glands, bowel and/or bladder, and sexual organs) are damaged. While diabetes is the most common cause of autonomic neuropathy, other health conditions or infections can also trigger autonomic neuropathy symptoms. Some medications have been shown to cause this particular kind of nerve damage as well.

  • Focal Neuropathy

One of the less common forms of neuropathy, Focal Neuropathy, sometimes referred to as mononeuropathy, affects a single nerve–commonly, those of the wrist, thigh, or foot, although it can sometimes affect the nerves of the back and chest, as well as those that control the eye muscles. Diabetes is often the root cause of this form of neuropathy.

Common Causes of Neuropathy

When it comes to identifying the cause of your neuropathy symptoms, a thorough evaluation is essential. Neuropathy may be caused by:

  • Structural abnormalities in the spinal vertebrae or bones and joints that may exert compression or alter the normal pathway of certain nerves
  • Traumas, injuries or compression exerted by tumors on the nerves
  • Diabetes
  • Autoimmune diseases
  • Exposure to toxic chemicals and metals
  • Genetic disorders
  • Virus or bacterial infections
  • Kidney or liver failure
  • Severe vitamin or mineral deficiencies caused by a poor diet or malnutrition
  • Endocrine disorders, such as hypothyroidism, may also cause damage to the nerves

To diagnose your particular symptoms, and to get to the root of your problem, involve a specialist at Spine Correction Center of the Rockies. Not only can a specialist uncover the cause of your symptoms, but they can also prescribe targeted treatment options to restore function and eliminate pain.

ODFs in Neuropathy

Neuropathy is characterized by nerve damage that often causes pain, numbness, and tingling. Vitamin B12 is essential for producing the myelin sheath (the protective coating of nerves).

Enhanced Compliance: Neuropathy patients, especially the elderly or those with diabetic complications, may suffer from dysphagia (difficulty swallowing). ODFs dissolve in seconds on the tongue without water.

Bypassing First-Pass Metabolism: Absorption through the oral mucosa (sublingual or buccal) can lead to higher bioavailability by entering the systemic circulation directly, bypassing the digestive tract where B12 absorption is often inefficient.

Non-Invasive: ODFs provide a painless alternative to intramuscular B12 injections. effectiveness of an ODF depends on the selection of polymers and excipients.

Component

Example Ingredients

Role in Formulation

Active Ingredient

Methylcobalamin

Active form of B12; neuroprotective agent.

Film-Forming Polymers

HPMC (E3, E5, E15), PVA, Pullulan, Maltodextrin

Provides structure, mechanical strength, and flexibility.

Plasticizers

PEG 400, Glycerol, Propylene Glycol

Reduces brittleness and improves film flexibility.

Super-disintegrants

Sodium Starch Glycolate, Crospovidone

Ensures the film dissolves rapidly (usually <60 seconds).

Sweeteners/Flavors

Aspartame, Sucralose, Menthol

Masks the metallic taste of B12 and improves mouthfeel.

A. Physical & Mechanical Tests

  • Thickness: Measured using a micrometer screw gauge at multiple points to ensure uniformity.
  • Folding Endurance: The film is repeatedly folded at the same place until it breaks. A high value (>200) indicates good flexibility.
  • Tensile Strength: Measures the force required to break the film; essential for withstanding packaging and handling.

B. Chemical & Dissolution Tests

  • Disintegration Time: Ideally, the film should disintegrate in the oral cavity within 15–60 seconds.
  • Drug Content Uniformity: Ensures each $4\text{cm}^2$ strip contains the exact labeled dose of Vitamin B12.
  • In-vitro Dissolution: Performed using a USP Dissolution Apparatus in simulated salivary fluid (pH 6.8) to see how quickly the drug is released.
  • Surface pH: Must be near neutral (6.5–7.0) to avoid irritating the oral mucosa.

Clinical Impact on Neuropathy

Methyl cobalamin in ODF form acts as a "painkiller" and "nerve regenerator":

  • Myelin Repair: It promotes the synthesis of lecithin, a major component of the myelin sheath.
  • Analgesic Effect: It can reduce the "ectopic firing" of injured nerves, which decreases the burning and stabbing pain associated with neuropathy.
  • Superior Absorption: For patients with GI issues (like those taking Metformin for diabetes, which blocks B12 absorption), the sublingual route provided by ODFs is significantly more effective.

Vitamin B12 deficiency, sometimes called cobalamin deficiency, happens when your body is either not getting enough or not absorbing enough vitamin B12 from the foods you eat. Vitamin B12 is an important nutrient that helps your body make red blood cells and DNA, the genetic material in all of your cells. It’s essential to how your body functions. Without treatment, vitamin B12 deficiency can cause physical, neurological and psychological problems. Vitamin B12 is an important nutrient that helps your body keep your nerve cells and red blood cells healthy. It also helps your body make DNA. Your body doesn’t make vitamin B12 on its own. You have to consume food and drinks that have vitamin B12 to get it. Vitamin B12 is found mostly in animal products, like fish, meat, dairy and eggs. It’s also in fortified foods (foods with vitamins and minerals added to them), like cereals, breads, plant-based milks and nutritional yeast. Adults need around 2.4 micrograms (mcg) of vitamin B12 a day. And women who are pregnant or breastfeeding need more. The amount of B12 babies and children need varies based on age. Two things need to happen for your body to absorb vitamin B12 from the food you eat:

  1. Hydrochloric acid in your stomach removes vitamin B12 from the food it is in.
  2. Vitamin B12 combines with something called intrinsic factor, a protein your stomach makes.

Your digestive system can then absorb B12.

Vitamin B12 deficiency anemia happens when your body doesn’t have enough healthy red blood cells. As B12 helps make red blood cells, a lack of vitamin B12 can cause anemia. But you can also have a vitamin B12 deficiency without having anemia. The symptoms of vitamin B12 deficiency can develop slowly and can get worse over time. You may have no symptoms despite having a low level of vitamin B12 in your body. Vitamin B12 deficiency can cause physical, neurological and psychological symptoms.

Physical symptoms can include:

  • Feeling very tired or weak
  • Experiencing nausea, vomiting or diarrhea
  • Not feeling as hungry as usual
  • Losing weight
  • Having a sore mouth or tongue ulcers
  • Having pale skin

Neurological symptoms can include:

  • Numbness or tingling in your hands and feet
  • Vision problems
  • Having a hard time remembering things or getting confused easily
  • Having a difficult time walking or speaking like you usually do

Psychological symptoms can include:

  • Feeling depressed
  • Feeling irritable
  • Experiencing a change in the way you feel or behave

Vitamin B12 deficiency happens if you aren’t eating enough vitamin B12 or your body isn’t absorbing the vitamin B12 you consume. Situations or conditions that can cause vitamin B12 deficiency include:

  • Lack of vitamin B12 in your diet: People who don’t eat enough foods that have vitamin B12 or don’t eat foods fortified with B12 can develop a deficiency.
  • Gastritis: Gastritis is inflammation of the stomach lining, and it’s a common cause of vitamin B12 deficiency. It can cause vitamin B12 deficiency due to a lack of hydrochloric acid in your stomach, which you need for B12 absorption.
  • Pernicious anemia: People who have pernicious anemia don’t make intrinsic factor. You need intrinsic factor so your body can absorb B12 vitamin. People with pernicious anemia have a B12 vitamin deficiency.

Risk factors

You are more likely to develop vitamin B12 deficiency if you have one or more of the following risk factors:

  • Being older than 75 years: People over 75 are more at risk for developing vitamin B12 deficiency because their bodies are often unable to fully absorb vitamin B12.
  • Having a digestive system disorder: Digestive disorders can make it more difficult for your body to absorb vitamin B12.
  • Following a vegan or vegetarian diet: Vitamin B12 is only naturally found in animal products, like meat and dairy. Because of this, people who eat a vegan or vegetarian diet are more likely to have a vitamin B12 deficiency if they aren’t taking a B12 supplement.

Complications of B12 deficiency

Left untreated, vitamin B12 deficiency can cause lasting side effects that affect your nervous system and brain. More severe side effects include:

  • Peripheral neuropathy
  • Degeneration of your spinal cord
  • Paralysis
  • Bowel incontinence and/ or urinary incontinence
  • Erectile dysfunction
  • Paranoia and delusions
  • Memory loss

Diagnosis a Test

It can be difficult to diagnose vitamin B12 deficiency because you may not have symptoms, or symptoms can be like other nutritional deficiencies. Healthcare providers will usually do blood tests to check for B12 deficiency in people who have a high risk of developing it.

Specific tests to help diagnose vitamin B12 deficiency are:

  • Complete blood count (CBC)
  • Vitamin B12 test
  • Methylmalonic acid (MMA) test
  • Homocysteine test

      Treatment

  • Vitamin B12 oral medication
  • Vitamin B12 injections
  • Vitamin B12 nasal spray or nasal gel
  • Eating more foods that are rich in B12 (like meat, fish, eggs and dairy)

CONCLUSION-

Vitamin B12 oral dispersible films formulated using suitable polymers provide an effective, patient-friendly alternative to conventional dosage forms. Their rapid disintegration, ease of administration, and enhanced compliance make them a promising approach for the management of neuropathy. Continued research and development may further optimize this delivery system for broader therapeutic applications. In conclusion, the development of Vitamin B12 (Methylcobalamin) Oral Dispersible Films (ODFs) represents a significant advancement in the pharmaceutical management of neuropathy. By utilizing biocompatible polymers like HPMC and PVA, this dosage form successfully addresses the primary challenges associated with traditional B12 therapy—namely, poor oral absorption in the GI tract and the needle-phobia associated with frequent injections.

REFERENCE

  1. Rizzo G, Laganà AS. A review of vitamin B12. Molecular nutrition. 2020 Jan 1:105-29.
  2. Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, Molloy AM, Nexo E, Stabler S, Toh BH, Ueland PM. Vitamin B12 deficiency. Nature reviews Disease primers. 2017 Jun 29;3(1):1-20.
  3. Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. Bmj. 2014 Sep 4;349.
  4. Shipton MJ, Thachil J. Vitamin B12 deficiency–A 21st century perspective. Clinical medicine. 2015 Apr 1;15(2):145-50.
  5. Rodionov DA, Vitreschak AG, Mironov AA, Gelfand MS. Comparative genomics of the vitamin B12 metabolism and regulation in prokaryotes. Journal of Biological Chemistry. 2003 Oct 17;278(42):41148-59.
  6. Ronald P, Shashank NN, Shwetha SKK, Shabaraya AR. Formulation and evaluation of fast dissolving tablets of flunarizine hydrochloride by sublimation method using sodium starch glycolate as superdisintegrant. Int J Pharm Tech Res 2014; 6:1085-95.
  7. Arpit SP, Shashank NN, Shwetha SKK, Dhaval MR, Shabaraya AR. Design development and evaluation of fast dissolving tablets of loratadine by direct compression method. Am J PharmTech Res 2013; 3:1-14.
  8. The United States pharmacopeia. National formulary. Vol. 1. Rockville (MD): United States Pharmacopeial Convention: Collodion; 2017.
  9. Siraj NS, Band A, Abdul R, Khan GJ. Formulation optimization and evaluation of gastroretentive tablets of ondansetron HCl. J Drug Delivery Ther 2018; 8:185-95.
  10. Anirudh SP, Harish G, Pragath KB, Debjit B, Duraivel S. Effect of super disintegrants on formulation of ondansetron HCL immediate release tablets by direct compression method. Int J Pharm Clin Res 2012; 4:61-7.
  11. Rajnikant MS, Narendra PC, Digesh DS. Formulation and evaluation of fast dissolving tablets of ondansetron by solid dispersion in superdisintegrants. Indian J Pharm Edu Res 2013; 47:49-55.
  12. Shyam RS, Bhupendra KP, Uttam B, Panna T. Taste masking and formulation of ondansetron hydrochloride mouth dissolving tablets. Int J Pharm Sci Res 2015; 6:856-64.
  13. Anupam R, Orodispersible tablets: a review. Asian J Pharm Clin Res 2016; 9:19-26. 10. Neelima RT, Lalitha KCT, Mallikarjun RB, Brahma RDR. Comparitive in vitro evaluation of different commercially available brands of pantoprazole tablets. Int J Pharm Sci Res 2012; 3:1108-11.
  14. Akira F, Norio YF, Taku N, Takenori N, Manabu S, Yasushi S, et al. Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations. Drug Des Devel Ther 2008; 2:139-44.
  15. Sravanthi M, Srinivasa RB. Design and evaluation of ondansetron fast disintegrating tablets using natural polymers and modified starches as super disintegrants for the enhancement of dissolution. J Young Pharm 2017; 9:519-24.
  16. Remya PN, Damodharan N, Lokendra S. Formulation and evaluation of fast disintegrating orodispersible tablets of ondansetron hydrochloride. J Pharm Sci Res 2012; 4:1810–3.
  17. Ved P, Saurabh M, Shiv KY, Hemlata, Vikas J. Fast disintergrating tablets: opportunity in drug delivery system. J Adv Pharm Technol Res 2011; 2:223-35.
  18. Nehal S, Garima G, Pramod KS. Fast dissolving tablets: preperation, characterization and evaluation: an overview. Int J Pharm Sci Rev Res 2015; 4:87-96.
  19. Sunidhi M, Shivali S, Sachin G, Bhimi K, Abhishek S. Formulation and evaluation of mouth dissolving tablets of ondansetron hydrochloride using plantago ovata (isapghula) mucilage as natural super disintegrating agent. Int J Pharm Sci Drug Res 2017; 9:240-6.
  20. Dixit RP, Puthli SP. Oral strip technology: Overview and future potential. J Control Release. 2009;139(2):94-107.
  21. Arun Arya, Amrish Chandra, Vijay Sharma and Kamla Pathak. Fast Dissolving Oral Films: An Innovative Drug Delivery System and Dosage Form. International Journal of ChemTech Research .2010;.2(1):576-583.
  22.  Naga Sowjanya Juluru. Fast Dissolving Oral Films: A Review. International journal of advances in pharmacy, biology and chemistry. 2013. 2(1):108-112.
  23.  B.P. Panda, N.S. Dey and M.E.B. Rao. Development of Innovative Orally Fast Disintegrating Film Dosage Forms: A Review. International journal of pharmaceutical science and Nanotechnology,2012.5(2):1666-1674.
  24.  Muhammad Irfana, Sumeira Rabel, Quratulain Bukhtar, Muhammad Qadir, Farhat Jabeen, Ahmed Khan. Orally Disintegrating Film:A modern expansion in drug delivery system. Saudi Pharmaceutical Journal, 2016.24(5): 537-546.
  25. Muhammad Bilal Hassan Mahboob, Tehseen Riaz, Muhammad Jamshaid, Irfan Bashirand Saqiba Zulfiqar. Oral Films: A Comprehensive Review, international Current Pharmaceutical Journal,2016. 5(12): 111-117.
  26. 7. Julie Mariam Joshua, R Hari, Fithal K Jyothish, Saritha A Surendran, Fast Dissolving Oral Thin Films: An Effective Dosage Form for Quick Releases, International Journal of Pharmaceutical Sciences Review and Research,2016.38(1) 282-289.
  27. Upendra C Galgatte, Sunil S Khanchandani, Yuvraj G Jadhav, Praveen D Chaudhari. Investigation Of Different Polymers, Plasticizers And Super disintegrating Agents Alone And In Combination For Use In The Formulation Of Fast Dissolving Oral Films: International Journal of PharmTech Research.2013.5(4): 1465-1472.
  28. Tatwashil Kshirsagar, Naresh Jaiswal, Gitanjali Chavan, Krushna Zambre, Sawandkar Ramkrushna and Deshmukh Dinesh. Formulation & evaluation of fast dissolving oral film, World Journal of Pharmaceutical Research 2024 .10(09):503-561.
  29. Manasa Chandramouli, Rajendra Prasad Shivalingappa, Vrushabendra Basavanna, Shridevi Doddamani, Dileep Chikkur Shanthakumar, Sandhya Rani Nagarajaiah, Srikantamurthy Ningaiah. Oral Thin-films from Design to Delivery: A Pharmaceutical Viewpoint, Bio interfere research in applied chemistry 2023,13(2):1-23.

Reference

  1. Rizzo G, Laganà AS. A review of vitamin B12. Molecular nutrition. 2020 Jan 1:105-29.
  2. Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, Molloy AM, Nexo E, Stabler S, Toh BH, Ueland PM. Vitamin B12 deficiency. Nature reviews Disease primers. 2017 Jun 29;3(1):1-20.
  3. Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. Bmj. 2014 Sep 4;349.
  4. Shipton MJ, Thachil J. Vitamin B12 deficiency–A 21st century perspective. Clinical medicine. 2015 Apr 1;15(2):145-50.
  5. Rodionov DA, Vitreschak AG, Mironov AA, Gelfand MS. Comparative genomics of the vitamin B12 metabolism and regulation in prokaryotes. Journal of Biological Chemistry. 2003 Oct 17;278(42):41148-59.
  6. Ronald P, Shashank NN, Shwetha SKK, Shabaraya AR. Formulation and evaluation of fast dissolving tablets of flunarizine hydrochloride by sublimation method using sodium starch glycolate as superdisintegrant. Int J Pharm Tech Res 2014; 6:1085-95.
  7. Arpit SP, Shashank NN, Shwetha SKK, Dhaval MR, Shabaraya AR. Design development and evaluation of fast dissolving tablets of loratadine by direct compression method. Am J PharmTech Res 2013; 3:1-14.
  8. The United States pharmacopeia. National formulary. Vol. 1. Rockville (MD): United States Pharmacopeial Convention: Collodion; 2017.
  9. Siraj NS, Band A, Abdul R, Khan GJ. Formulation optimization and evaluation of gastroretentive tablets of ondansetron HCl. J Drug Delivery Ther 2018; 8:185-95.
  10. Anirudh SP, Harish G, Pragath KB, Debjit B, Duraivel S. Effect of super disintegrants on formulation of ondansetron HCL immediate release tablets by direct compression method. Int J Pharm Clin Res 2012; 4:61-7.
  11. Rajnikant MS, Narendra PC, Digesh DS. Formulation and evaluation of fast dissolving tablets of ondansetron by solid dispersion in superdisintegrants. Indian J Pharm Edu Res 2013; 47:49-55.
  12. Shyam RS, Bhupendra KP, Uttam B, Panna T. Taste masking and formulation of ondansetron hydrochloride mouth dissolving tablets. Int J Pharm Sci Res 2015; 6:856-64.
  13. Anupam R, Orodispersible tablets: a review. Asian J Pharm Clin Res 2016; 9:19-26. 10. Neelima RT, Lalitha KCT, Mallikarjun RB, Brahma RDR. Comparitive in vitro evaluation of different commercially available brands of pantoprazole tablets. Int J Pharm Sci Res 2012; 3:1108-11.
  14. Akira F, Norio YF, Taku N, Takenori N, Manabu S, Yasushi S, et al. Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations. Drug Des Devel Ther 2008; 2:139-44.
  15. Sravanthi M, Srinivasa RB. Design and evaluation of ondansetron fast disintegrating tablets using natural polymers and modified starches as super disintegrants for the enhancement of dissolution. J Young Pharm 2017; 9:519-24.
  16. Remya PN, Damodharan N, Lokendra S. Formulation and evaluation of fast disintegrating orodispersible tablets of ondansetron hydrochloride. J Pharm Sci Res 2012; 4:1810–3.
  17. Ved P, Saurabh M, Shiv KY, Hemlata, Vikas J. Fast disintergrating tablets: opportunity in drug delivery system. J Adv Pharm Technol Res 2011; 2:223-35.
  18. Nehal S, Garima G, Pramod KS. Fast dissolving tablets: preperation, characterization and evaluation: an overview. Int J Pharm Sci Rev Res 2015; 4:87-96.
  19. Sunidhi M, Shivali S, Sachin G, Bhimi K, Abhishek S. Formulation and evaluation of mouth dissolving tablets of ondansetron hydrochloride using plantago ovata (isapghula) mucilage as natural super disintegrating agent. Int J Pharm Sci Drug Res 2017; 9:240-6.
  20. Dixit RP, Puthli SP. Oral strip technology: Overview and future potential. J Control Release. 2009;139(2):94-107.
  21. Arun Arya, Amrish Chandra, Vijay Sharma and Kamla Pathak. Fast Dissolving Oral Films: An Innovative Drug Delivery System and Dosage Form. International Journal of ChemTech Research .2010;.2(1):576-583.
  22.  Naga Sowjanya Juluru. Fast Dissolving Oral Films: A Review. International journal of advances in pharmacy, biology and chemistry. 2013. 2(1):108-112.
  23.  B.P. Panda, N.S. Dey and M.E.B. Rao. Development of Innovative Orally Fast Disintegrating Film Dosage Forms: A Review. International journal of pharmaceutical science and Nanotechnology,2012.5(2):1666-1674.
  24.  Muhammad Irfana, Sumeira Rabel, Quratulain Bukhtar, Muhammad Qadir, Farhat Jabeen, Ahmed Khan. Orally Disintegrating Film:A modern expansion in drug delivery system. Saudi Pharmaceutical Journal, 2016.24(5): 537-546.
  25. Muhammad Bilal Hassan Mahboob, Tehseen Riaz, Muhammad Jamshaid, Irfan Bashirand Saqiba Zulfiqar. Oral Films: A Comprehensive Review, international Current Pharmaceutical Journal,2016. 5(12): 111-117.
  26. 7. Julie Mariam Joshua, R Hari, Fithal K Jyothish, Saritha A Surendran, Fast Dissolving Oral Thin Films: An Effective Dosage Form for Quick Releases, International Journal of Pharmaceutical Sciences Review and Research,2016.38(1) 282-289.
  27. Upendra C Galgatte, Sunil S Khanchandani, Yuvraj G Jadhav, Praveen D Chaudhari. Investigation Of Different Polymers, Plasticizers And Super disintegrating Agents Alone And In Combination For Use In The Formulation Of Fast Dissolving Oral Films: International Journal of PharmTech Research.2013.5(4): 1465-1472.
  28. Tatwashil Kshirsagar, Naresh Jaiswal, Gitanjali Chavan, Krushna Zambre, Sawandkar Ramkrushna and Deshmukh Dinesh. Formulation & evaluation of fast dissolving oral film, World Journal of Pharmaceutical Research 2024 .10(09):503-561.
  29. Manasa Chandramouli, Rajendra Prasad Shivalingappa, Vrushabendra Basavanna, Shridevi Doddamani, Dileep Chikkur Shanthakumar, Sandhya Rani Nagarajaiah, Srikantamurthy Ningaiah. Oral Thin-films from Design to Delivery: A Pharmaceutical Viewpoint, Bio interfere research in applied chemistry 2023,13(2):1-23.

Photo
Vaishnavi Salunke
Corresponding author

RJS College of Pharmacy Kokamthan, Koapargaon

Photo
Amrita Singh
Co-author

RJS College of Pharmacy Kokamthan, Koapargaon

Vaishnavi Salunke*, Amrita Singh, Formulation and Evaluation of a Vitamin B12 Oral Dispersible Film Using Polymers for Enhanced Patient Compliance in Neuropathy– A Review, Int. J. Sci. R. Tech., 2026, 3 (1), 117-125. https://doi.org/10.5281/zenodo.18170845

More related articles
Screening and Early Diagnosis of Ovarian Cancer: A...
Ashlesha Chavhan, Kiran Kambale, Vishal Bhoye, Sani Gaikwad, Prac...
Immunopharmacology of Trained Immunity in Infectio...
Pratiksha Vyavahare, Kranti Akhare, Dr. N. P. Sawadadkar, Dr. N. ...
Formulation and Evaluation of Poly Herbal Face Pac...
Harshal Mahajan, Satyashila Mhaske, Dr. G. R. Sitaphale, Dr. P. R...
Some Ridge Biasing Parameter for Linear Regression Model and Their Performances ...
Raheed Saheed Lekan, Owolabi Muhammed Ishola, James Olasunkanmi Oladapo, Olabode John Oluwasina, Faw...
Related Articles
Neuropharmacology in the Era of Digital Psychiatry: Targeting Glutamatergic Imba...
Rahul Bobade, Vaishanvi Saste, Arti Mapari, Chakradhar Kadam, Mohan Tale, Dr. Nilesh Sawadadkar, Dr....
A Review on RNA-Based Therapeutics: Mechanisms, Applications, and Future Prospec...
Kranti Akhare, Pratiksha Vyavahare, S. K. Mohrut, Dr. N. R. Kayande, ...
Design of Experiments in the Formulation and Optimization of Sustained Release M...
Kartik Shinde, Dr. Nilesh Gorde, Swapnil Phalak, Prajval Birajdar, Vishal Bodke, ...
A Unified Video Content Understanding Framework for Youtube and Local Videos wit...
M. Manjunath, M. Shashank, Sai Gagan Tej K. B. , C. Sharath Vamshi, Srisailanath, ...
Screening and Early Diagnosis of Ovarian Cancer: An Updated Review...
Ashlesha Chavhan, Kiran Kambale, Vishal Bhoye, Sani Gaikwad, Prachi Gaikwad, Pooja Rasal, ...
More related articles
Screening and Early Diagnosis of Ovarian Cancer: An Updated Review...
Ashlesha Chavhan, Kiran Kambale, Vishal Bhoye, Sani Gaikwad, Prachi Gaikwad, Pooja Rasal, ...
Immunopharmacology of Trained Immunity in Infectious and Non-Infectious Diseases...
Pratiksha Vyavahare, Kranti Akhare, Dr. N. P. Sawadadkar, Dr. N. R. Kayande, ...
Formulation and Evaluation of Poly Herbal Face Pack...
Harshal Mahajan, Satyashila Mhaske, Dr. G. R. Sitaphale, Dr. P. R. Laddha, Dr. P. R. Tathe, ...
Screening and Early Diagnosis of Ovarian Cancer: An Updated Review...
Ashlesha Chavhan, Kiran Kambale, Vishal Bhoye, Sani Gaikwad, Prachi Gaikwad, Pooja Rasal, ...
Immunopharmacology of Trained Immunity in Infectious and Non-Infectious Diseases...
Pratiksha Vyavahare, Kranti Akhare, Dr. N. P. Sawadadkar, Dr. N. R. Kayande, ...
Formulation and Evaluation of Poly Herbal Face Pack...
Harshal Mahajan, Satyashila Mhaske, Dr. G. R. Sitaphale, Dr. P. R. Laddha, Dr. P. R. Tathe, ...